China successfully completes the country#s first human implantation of a retrievable transcatheter aortic valve

Food and Healthcare Press Releases Wednesday November 29, 2017 08:54
HANGZHOU, China--29 Nov--PRNewswire/InfoQuest
  • The success of the procedure unleashes a new era for retrievable interventional cardiac valve technology in China
The first human implantation of the VenusA Plus retrievable valve system was completed successfully at the Second Affiliated Hospital of Zhejiang University School of Medicine (SAHZU) on November 23, 2017.
https://photos.prnasia.com/prnvar/20171124/2000223-1

Prof. Wang Jian'an, president of SAHZU, announced that China has completed its first successful human implantation of a retrievable transcatheter aortic valve. It marks another milestone for Venus Medtech, becoming China's first company capable of providing a retrievable interventional cardiac valve system.

The 76-year-old female patient who was operated on using the system had been diagnosed with severe aortic valve stenosis and defined as a high-risk surgical patient. The heart team discussed and defined the patient's anatomical features as a bicuspid aortic valve and asymmetric calcification, which raised the risk of dislocation during the valve implantation. They were of the opinion that the retrievable system would be the best fit for the patient.

The retrievable system allows the valve to withdraw and reposition after release, avoiding adverse events as a result of a poor implant position and mismatch of the implanted valve, including valve translocation, severe paravalvular leakage, a negative impact on the bicuspid aortic valve and high degree atrioventricular block caused by conduction bundle compression. The system also reduces the complexity of the procedure, which, in turn, helps to promote the adoption and application of TAVR technology.

"SAHZU's medical team has been closely working with Zhejiang Province's Cardiac Valve Research Institute and Venus Medtech's R&D team to study, develop and produce the heart valve products. The collaboration began with the VenusA-Valve and has led to the success for VenusA Plus," professor Wang added. "The product is a next-generation TAVR valve that delivers good performance in terms of release, retrievable stability, controllability and passing ability, thus offering great potential when it comes to clinical applications."

The successful human implantation of VenusA Plus took place just four months after the launch of China's first TAVR valve VenusA-Valve. "Venus Medtech has continuously achieved technological breakthroughs," explained Venus Medtech CEO Zi Zhenjun. "We plan to roll out more innovative products going forward, demonstrating the company's strong competence in innovation and its ongoing commitment to serving patients."

Photo - https://photos.prnasia.com/prnh/20171124/2000223-1

Latest Press Release

The Consumer Health of Merck Walks the Talk with its WE100 Movement

- Consumer Health accelerates its WE100(R) movement by launching new partnership programme with pharmacists in the UK on enabling 100 years of healthy living - Femibion(R) celebrates working mums with new "MumPlus" campaign - Expansion of Vitamin D brand...

Mindray launches BeneVision N1 for uninterrupted monitoring during intra and out-of-hospital patient transport

The revolutionary transport solution extends intelligent monitoring to out-of-hospital transport settings such as ambulances, helicopters, and civic flights. Mindray, a global medical equipment solution provider, announced the release of BeneVision N1...

Photo Release: Fujitsu works with the Thai Red Cross Society to contribute to society through the annual 20th FTH Voluntary Blood Donation Day

Ms. Krittinee Sivakul, Head of HR & Administration Group, Fujitsu (Thailand) Co., Ltd. (FTH) led a group comprising company management and staff at a special executives and 187 employees of the company recently donated blood to the Thai Red Cross...

Systech Europe(TM) Announces Rapid Expansion of Customer Base and Pharmaceutical Serialisation Partners Ready to Meet the FMD Regulation

Systech International , the global technology leader in serialisation, track and trace, and brand protection grew its European presence in 2017 by 50% with new accounts in France, Germany, Greece, Turkey, and Finland. The company also added new...

Fluke Biomedical VT650 and VT900 Gas Flow Analyzers offer the highest accuracy on the market

New analyzers deliver ease-of-use and reliability in measurements for all types of ventilators, flow meters, pressure gauges, anesthesia machines, and other devices Fluke Biomedical introduces the VT650 and VT900 Gas Flow Analyzers , which include...

Related Topics